cell line

Horizon Discovery Group, gene editing and modulation technologies company, has entered into a non-exclusive out-licensing agreement with a US-based immune-oncology therapeutics developer. more


The Austrian Centre of Industrial Biotechnology and pharmaceutical company GE Healthcare have announced a cell line engineering research collaboration in an attempt to bring increased productivity to biomanufacturers. more


Cellca — catering for biopharma companies and biosimilar firms that do not or only partly conduct their cell line and process development in-house — has been acquired by Sartorius Stedim Biotech. more


Horizon Discovery Group's CombinatoRx division has been contracted by Otsuka Pharmaceutical Development and Commercialization (OPDC) to perform in vitro cell line screening of certain OPDC development candidate(s). more

Catalent Pharma Solutions has reached a commercial cell line sales agreement with CEVEC Pharmaceuticals for recombinant human alpha-1 antitrypsin (hAAT). more